Korro Bio Inc (KRRO)

Jun 15, 2026

Korro Bio: RNA Editor Plots Way Back After AATD Study FailI'm Holding (NASDAQ:KRRO) - Seeking Alpha

Jun 15, 2026

Jun 13, 2026

KRRO Q1 2026 Earnings: Narrowed Loss Surprises to the Upside, Shares RallyEarnings Surprise Stocks - newsline.com

Jun 13, 2026

Jun 12, 2026

KORRO BIO INC (KRRO) Stock Chart - ChartMill

Jun 12, 2026

Jun 12, 2026

Korro Bio Stockholders Approve Directors, Pay and Auditor - The Globe and Mail

Jun 12, 2026

Jun 11, 2026

Korro Bio (KRRO) director Ali Behbahani receives 14,677 stock options grant - Stock Titan

Jun 11, 2026

Jun 11, 2026

Korro Bio (KRRO) director receives 14,677 stock options at $10.59 strike - Stock Titan

Jun 11, 2026

Jun 11, 2026

Korro Bio (KRRO) director Nessan Bermingham receives 14,677 stock options at $10.59 - Stock Titan

Jun 11, 2026

Jun 11, 2026

Korro Bio (KRRO) director awarded 14,677 stock options at $10.59 strike price - Stock Titan

Jun 11, 2026

Jun 11, 2026

Director at Korro Bio (NASDAQ: KRRO) awarded stock options for 14,677 shares - Stock Titan

Jun 11, 2026

Jun 11, 2026

Korro Bio (NASDAQ: KRRO) director receives 14,677 stock options grant - Stock Titan

Jun 11, 2026

Jun 11, 2026

What makes Korro Bio, Inc. (KRRO) a new buy stock - MSN

Jun 11, 2026

Jun 11, 2026

Korro Bio (NASDAQ: KRRO) investors back directors, pay and auditor - Stock Titan

Jun 11, 2026

Jun 11, 2026

One Korro Bio Insider Raised Stake By 19% In Previous Year - Yahoo Finance

Jun 11, 2026

Jun 10, 2026

KRRO Q1 2026 Earnings: Narrower-than-expected loss drives positive surprise despite revenue absenceNext Quarter Guidance - newsline.com

Jun 10, 2026

Jun 06, 2026

KRRO Q1 2026 Earnings: EPS Beat But Stock Declines Amid No RevenueAnnual Report - newsline.com

Jun 06, 2026

Jun 05, 2026

KRRO Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline Amid Pre-Revenue PhaseManagement Tone Analysis - newsline.com

Jun 05, 2026

Jun 02, 2026

Korro Bio CEO Ram Aiyar sells $196,672 in company stock By Investing.com - Investing.com Nigeria

Jun 02, 2026

Jun 02, 2026

Korro Bio CEO Ram Aiyar sells $196,672 in company stock - Investing.com

Jun 02, 2026

Jun 02, 2026

Korro Bio Shares Slide 6% as Stock Tests Key Support LevelsTechnical Analysis - newsline.com

Jun 02, 2026

Jun 01, 2026

Korro Bio director sells $39,897 in common stock By Investing.com - Investing.com Canada

Jun 01, 2026

Jun 01, 2026

Korro Bio director sells $39,897 in common stock - Investing.com

Jun 01, 2026

May 29, 2026

Korro Bio Inc. (KRRO) Faces Selling Pressure as Shares Retreat 3.21%Bear Pennant - The Legal Advocate

May 29, 2026

May 29, 2026

KRRO Q1 2026 Earnings: EPS Beat by 10.05% as Biotech Advances PipelineNext Quarter Guidance - The Legal Advocate

May 29, 2026

May 29, 2026

Press Release: Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors - Moomoo

May 29, 2026

May 28, 2026

Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $30 - Moomoo

May 28, 2026

May 28, 2026

Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates - MSN

May 28, 2026

May 28, 2026

Korro Bio | 4: Statement of changes in beneficial ownership of securities-Officer Aiyar Ram - Moomoo

May 28, 2026

May 27, 2026

Korro Bio, Inc. identifies surge in healthcare burden from ammonia in hepatic encephalopathy - Traders Union

May 27, 2026

May 27, 2026

Korro Bio (KRRO) Receives a Buy from H.C. Wainwright - The Globe and Mail

May 27, 2026

May 27, 2026

Korro to Present at the 2026 Jefferies Global Healthcare Conference - The Manila Times

May 27, 2026

May 26, 2026

H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo

May 26, 2026

May 23, 2026

Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come - Bez Kabli

May 23, 2026

May 23, 2026

KRRO Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionPreliminary Results - newsline.com

May 23, 2026

May 21, 2026

Korro Bio Inc. (KRRO) Surges Nearly 12% as Biotech Momentum BuildsExpert Momentum Signals - Newser

May 21, 2026

May 21, 2026

Citigroup initiates coverage of Korro Bio (KRRO) with buy recommendation - MSN

May 21, 2026

May 20, 2026

Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 – Minichart - minichart.com.sg

May 20, 2026

May 19, 2026

What is Korro Bio, Inc. (KRRO) stock_business overview_development history - Bitget

May 19, 2026

May 19, 2026

Korro Bio, Inc.Common Stock (NQ: KRRO - The Chronicle-Journal

May 19, 2026

May 19, 2026

Korro Bio adds AATD treatment candidate to pipeline By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

H.C. Wainwright cuts Korro Bio stock price target on financing impact By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Korro Bio nominates new candidate for AATD - BioWorld News

May 19, 2026

May 19, 2026

H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

May 19, 2026

May 19, 2026

Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union

May 19, 2026

May 19, 2026

H.C. Wainwright cuts Korro Bio stock price target on financing impact - Investing.com Nigeria

May 19, 2026

May 19, 2026

Korro Bio Advances KRRO-111 for Alpha-1 Deficiency - TipRanks

May 19, 2026

May 19, 2026

Korro Bio adds AATD treatment candidate to pipeline - Investing.com

May 19, 2026

May 18, 2026

KRRO Initiates Coverage by Citigroup -- Announces Buy Rating - GuruFocus

May 18, 2026

May 18, 2026

Citi Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $21 - Moomoo

May 18, 2026

May 18, 2026

Lynx1 Capital Management LP's Korro Bio Inc(KRRO) Holding History - GuruFocus

May 18, 2026